Wed, January 3, 2024
Tue, January 2, 2024
Fri, December 29, 2023
Thu, December 28, 2023
Wed, December 27, 2023
Tue, December 26, 2023
Fri, December 22, 2023
Thu, December 21, 2023
Wed, December 20, 2023
Tue, December 19, 2023

Mara Goldstein Initiated (SNDX) at Strong Buy and Held Target at $45 on, Dec 22nd, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. -buy-and-held-target-at-45-on-dec-22nd-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Mara Goldstein of Mizuho, Initiated "Syndax Pharmaceuticals, Inc." (SNDX) at Strong Buy and Held Target at $45 on, Dec 22nd, 2023.

Mara has made no other calls on SNDX in the last 4 months.



There are 5 other peers that have a rating on SNDX. Out of the 5 peers that are also analyzing SNDX, 0 agree with Mara's Rating of Hold.



These are the ratings of the 5 analyists that currently disagree with Mara


  • Bradley Canino of "Stifel" Maintained at Strong Buy with Decreased Target to $36 on, Thursday, October 26th, 2023
  • Jason Zemansky of "B of A Securities" Initiated at Strong Buy and Held Target at $29 on, Wednesday, October 25th, 2023
  • Anupam Rama of "JP Morgan" Maintained at Buy with Increased Target to $38 on, Tuesday, October 17th, 2023
  • Chris Shibutani of "Goldman Sachs" Initiated at Strong Buy and Held Target at $30 on, Wednesday, October 11th, 2023
  • Joel Beatty of "Baird" Maintained at Buy with Decreased Target to $28 on, Tuesday, October 3rd, 2023

Publication Contributing Sources